Authors:
CHAUDHRY S
KOZHICH AT
CHAN CC
SREDNI B
NUSSENBLATT RB
WHITECUP SM
Citation: S. Chaudhry et al., THE IMMUNOMODULATOR AS101 INHIBITS ENDOTOXIN-INDUCED UVEITS IN THE RAT, Investigative ophthalmology & visual science, 37(3), 1996, pp. 2477-2477
Citation: U. Gafter et al., BLOOD-TRANSFUSION ENHANCES PRODUCTION OF T-HELPER-2 CYTOKINES AND TRANSFORMING GROWTH-FACTOR-BETA IN HUMANS, Clinical science, 91(4), 1996, pp. 519-523
Citation: H. Rosenblattbin et al., ANTIBABESIAL EFFECT OF THE IMMUNOMODULATOR AS101 IN MICE - ROLE OF INCREASED PRODUCTION OF NITRIC-OXIDE, Parasite immunology, 18(6), 1996, pp. 297-306
Citation: Y. Kalechman et B. Sredni, DIFFERENTIAL EFFECT OF THE IMMUNOMODULATOR AS101 ON B7-1 AND B7-2 COSTIMULATORY MOLECULES - ROLE IN THE ANTITUMORAL EFFECTS OF AS101, The Journal of immunology, 157(2), 1996, pp. 589-597
Authors:
KALECHMAN Y
SHANI A
DOVRAT S
WHISNANT JK
METTINGER K
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., THE ANTITUMORAL EFFECT OF THE IMMUNOMODULATOR AS101 AND PACLITAXEL (TAXOL) IN A MURINE MODEL OF LUNG ADENOCARCINOMA, The Journal of immunology, 156(3), 1996, pp. 1101-1109
Authors:
SREDNI B
XU RH
ALBECK M
GAFTER U
GAL R
SHANI A
TICHLER T
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
WHISNANT JK
METTINGER KL
KALECHMAN Y
Citation: B. Sredni et al., THE PROTECTIVE ROLE OF THE IMMUNOMODULATOR AS101 AGAINST CHEMOTHERAPY-INDUCED ALOPECIA STUDIES ON HUMAN AND ANIMAL-MODELS, International journal of cancer, 65(1), 1996, pp. 97-103
Citation: Rh. Xu et al., THE CYTOPROTECTIVE EFFECT OF THE IMMUNOMODULATOR AS101 AGAINST HYDROCHLORIDE INDUCED GASTRIC-LESIONS, Research communications in molecular pathology and pharmacology, 87(1), 1995, pp. 4-20
Authors:
SREDNI B
ALBECK M
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
CATANE R
KAUFMAN B
KALECHMAN Y
Citation: B. Sredni et al., BONE MARROW-SPARING AND PREVENTION OF ALOPECIA BY AS1O1 IN NON-SMALL-CELL LUNG-CANCER PATIENTS TREATED WITH CARBOPLATIN AND ETOPOSIDE, Journal of clinical oncology, 13(9), 1995, pp. 2342-2353
Authors:
FISHMAN P
FALACHVAKNIN E
SREDNI B
MERONI PL
RUDNIKI C
SHOENFELD Y
Citation: P. Fishman et al., ASPIRIN MODULATES INTERLEUKIN-3 PRODUCTION - ADDITIONAL EXPLANATION FOR THE PREVENTIVE EFFECTS OF ASPIRIN IN ANTIPHOSPHOLIPID ANTIBODY SYNDROME, Journal of rheumatology, 22(6), 1995, pp. 1086-1090
Authors:
KALECHMAN Y
SHANI A
DOVRAT S
ALBECK M
BRUCKNER HW
SREDNI B
Citation: Y. Kalechman et al., SYNERGISTIC ANTITUMOR EFFECT OF THE IMMUNOMODULATOR ASIOI AND TAXOL IN EXPERIMENTAL MURINE MODEL, Experimental hematology, 23(8), 1995, pp. 799-799
Authors:
SREDNI B
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
TICHLER T
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY ASIOI IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDVP-16, Experimental hematology, 23(8), 1995, pp. 858-858
Authors:
KALECHMAN Y
RUSHKIN G
NERUBAY J
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., EFFECT OF THE IMMUNOMODULATOR AS101 ON CHEMOTHERAPY-INDUCED MULTILINEAGE MYELOSUPPRESSION, THROMBOCYTOPENIA, AND ANEMIA IN MICE, Experimental hematology, 23(13), 1995, pp. 1358-1366
Citation: Y. Kalechman et al., INDUCTION OF ACUTE-PHASE PROTEINS IN MICE AND HUMANS BY TREATMENT WITH AS101, AN IMMUNOMODULATOR WITH RADIOPROTECTIVE PROPERTIES, Immunopharmacology, 29(2), 1995, pp. 149-158
Authors:
SHALIT F
SREDNI B
BRODIE C
KOTT E
HUBERMAN M
Citation: F. Shalit et al., T-LYMPHOCYTE SUBPOPULATIONS AND ACTIVATION MARKERS CORRELATE WITH SEVERITY OF ALZHEIMERS-DISEASE, Clinical immunology and immunopathology, 75(3), 1995, pp. 246-250
Authors:
HUBERMAN M
SREDNI B
STERN L
KOTT E
SHALIT F
Citation: M. Huberman et al., IL-2 AND IL-6 SECRETION IN DEMENTIA - CORRELATION WITH TYPE AND SEVERITY OF DISEASE, Journal of the neurological sciences, 130(2), 1995, pp. 161-164
Authors:
GROSSMAN N
GOREN R
REUVENI H
HALEVY S
SREDNI B
LUBART R
Citation: N. Grossman et al., ROLE OF SUPEROXIDES PRODUCTION AND PKC ACTIVITY IN UVA-INDUCED HYPERPROLIFERATION OF KERATINOCYTE CULTURES, Journal of investigative dermatology, 104(4), 1995, pp. 601-601
Authors:
KALECHMAN Y
ZULOFF A
ALBECK M
STRASSMANN G
SREDNI B
Citation: Y. Kalechman et al., ROLE OF ENDOGENOUS CYTOKINES SECRETION IN RADIOPROTECTION CONFERRED BY THE IMMUNOMODULATOR AMMONIUM TRICHLORO(DIOXYETHYLENE-0-0')TELLURATE, Blood, 85(6), 1995, pp. 1555-1561
Authors:
GAFTER U
KALECHMAN Y
KORZETS A
WEINSTEIN T
ZEVIN D
SREDNI B
Citation: U. Gafter et al., A BLOOD-TRANSFUSION (BT) STIMULATES SECRETION OF IL-4 AND IL-10, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1005-1005
Authors:
GAFTER U
SEGAL J
KALECHMAN Y
CHAGNAC A
ORI Y
SREDNI B
Citation: U. Gafter et al., WHITE BLOOD-CELLS (WBC) IMMUNOTHERAPY IN HUMANS SUPPRESSES CELLULAR-IMMUNITY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1005-1005
Authors:
MCFADDEN A
KOSTUCHENKO P
BARRETT S
SREDNI B
BEAR HD
Citation: A. Mcfadden et al., IN-VITRO ACTIVATION AND EXPANSION OF ANTITUMOR T-CELLS WITH BRYOSTATIN-1 AND AS101, The FASEB journal, 8(5), 1994, pp. 10000773-10000773
Authors:
SHALIT F
SREDNI B
STERN L
KOTT E
HUBERMAN M
Citation: F. Shalit et al., ELEVATED INTERLEUKIN-6 SECRETION LEVELS BY MONONUCLEAR-CELLS OF ALZHEIMERS PATIENTS, Neuroscience letters, 174(2), 1994, pp. 130-132
Citation: B. Sredni et al., THE ROLE OF INTERLEUKIN-1 (IL-1), TUMOR-NECROSIS-FACTOR (TNF) AND INTERLEUKIN-6 (IL-6) IN THE RADIOPROTECTIVE PROPERTIES EXERTED BY AMMONIUM TRICHLORO(DIOXYETHYLENE-O-O')TELLURATE (AS101), Experimental hematology, 22(8), 1994, pp. 684-684
Authors:
SREDNI B
SHAPIRO Y
SHANI A
BRUDERMAN Y
CATANE R
KAUFMAN B
PAVLOTSKY F
KALECHMAN Y
ALBECK M
TICHLER T
Citation: B. Sredni et al., HAIR PRESERVATION AND PLATELET GRANULOCYTE SPARING EFFECT USING AS101WITH CHEMOTHERAPY - A RANDOMIZED STUDY/, Experimental hematology, 22(8), 1994, pp. 809-809
Authors:
DASTGHEIB K
HIKITA N
SREDNI B
ALBECK M
SREDNI D
NUSSENBLATT RB
CHAN CC
Citation: K. Dastgheib et al., OCULAR INFLAMMATION STIMULATED BY THE IMMUNOMODULATOR AS101 [AMMONIUMTRICHLORO(DIOXYETHELENE-O-O') TELLURATE], Current eye research, 13(8), 1994, pp. 603-610